COMP <GO>
STE vs LLY // OPERATING MARGIN
STERIS plc (Ireland) (NYSE) VS. Eli Lilly and Company (NYSE) • 15-METRIC TALLY: STE 4
— LLY 10
▲ OPERATING MARGIN LEADER: LLY
LAST: $227.12 (-2.16%) • MKT CAP: $22.63B
operating-margins
18.60%
LAST: $1,417.54 (+3.19%) • MKT CAP: $1.33T
operating-margins
40.21%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (STE VS. LLY)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | STE | LLY | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 44.20% | 83.64% | -39.44 | LLY | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 10.10% | 32.36% | -22.26 | LLY | /roic <GO> |
| EV/EBITDA & P/E Valuation | 17.0x | 36.4x | -19.42 | STE | /valuation <GO> |
| Free Cash Flow Yield | 4.30% | 2.30% | +2.00 | STE | /fcf-yield <GO> |
| Operating Margin ACTIVE | 18.60% | 40.21% | -21.61 | LLY | /operating-margins <GO> |
| Net Profit Margin | 13.20% | 31.90% | -18.70 | LLY | /net-margins <GO> |
| Revenue Growth (YoY) | 8.70% | 45.51% | -36.81 | LLY | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.07% | 0.49% | +0.58 | STE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.40 | 9.29 | -3.89 | LLY | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 9/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.20% | 6.77% | +0.43 | LLY | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 56.9 | 77.9 | -20.98 | LLY | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.08 | 0.51 | +0.57 | STE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 26.9x | 26.3x | +0.65 | LLY | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $22.63B | $1.33T | -$1.31T | LLY | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | STE REV | LLY REV | STE GROSS % | LLY GROSS % | STE FCF | LLY FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $5.94B | $65.18B | 44.2% | 83.0% | $972.4M | $16.81B |
| FY 2024 | $5.46B | $45.04B | 44.0% | 81.3% | $778.0M | $8.82B |
| FY 2023 | $5.14B | $34.12B | 44.0% | 79.3% | $742.1M | $4.24B |
| FY 2022 | — | $28.54B | — | 76.8% | — | $7.59B |
| FY 2021 | — | $28.32B | — | 74.2% | — | $7.37B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
STE // BETA 1.08
LLY // BETA 0.51